Lenalidomide and genetic profiling in myeloma, T-cell immunotherapy upregulates AML cell MHC-class II, and young fecal microbiota rejuvenate HSCs
Blood Podcast
00:00
Introduction
The April 6th, 2023 episode of Blood Podcast is your source for innovative ideas and cutting-edge information. First on today's podcast, optimizing the value of post-transplant lenalidomide maintenance in multiple myeloma. Up next, T-cell immunotherapies targeting AML antigens up-regulate MHC Class II expression on AML cells. Finally, young bugs rejuvenate old blood.
Transcript
Play full episode
